FinscoFinsco

Insmed (US.INSM)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.INSM · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion101.6%→
ROE-23.2%↑
Cash Conversion-→
D/E Ratio0.82↑
Gross Margin84.5%↑
US.INSM (Insmed) | YoY: 2026 Q1 vs 2025 Q1


Metric            Value  YoY
----------------------------
FCF Conversion   101.6%    →
ROE              -23.2%    ↑
Cash Conversion       -    →
D/E Ratio          0.82    ↑
Gross Margin      84.5%    ↑
Key Metrics
US.INSM (Insmed) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
----------------------------
FCF Conversion 101.6% →
ROE -23.2% ↑
Cash Conversion - →
D/E Ratio 0.82 ↑
Gross Margin 84.5% ↑

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies